Tysabri Study Participants To Undergo MRI, Physical In Search For Cause Of Adverse Events

Biogen Idec and Elan are suspending Tysabri clinical trials and conducting MRIs and physicals on trial participants as part of their voluntary marketing suspension of the multiple sclerosis therapy, the companies said